{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:14:54Z","timestamp":1704759294879},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:00:00Z","timestamp":1697414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00105-023-05241-3","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T08:01:54Z","timestamp":1697443314000},"page":"927-936","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Management von bull\u00f6sem Pemphigoid und Schleimhautpemphigoid","Management of bullous pemphigoid and mucous membrane pemphigoid"],"prefix":"10.1007","volume":"74","author":[{"given":"Johannes S.","family":"Kern","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silke C.","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,16]]},"reference":[{"key":"5241_CR1","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/jdv.18931","volume":"37","author":"E Antiga","year":"2023","unstructured":"Antiga\u00a0E, Bech\u00a0R, Maglie\u00a0R et\u00a0al (2023) S2k guidelines on the management of paraneoplastic pemphigus\/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV). J\u00a0Eur Acad Dermatol Venereol 37:1118\u20131134","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5241_CR2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.annder.2011.01.012","volume":"138","author":"C Bedane","year":"2011","unstructured":"Bedane\u00a0C, Doffoel Hantz\u00a0V (2011) Mucous membrane pemphigoid: a\u00a0review. Ann Dermatol Venereol 138:201\u2013208","journal-title":"Ann Dermatol Venereol"},{"key":"5241_CR3","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1111\/jdv.18220","volume":"36","author":"L Borradori","year":"2022","unstructured":"Borradori\u00a0L, Van Beek\u00a0N, Feliciani\u00a0C et\u00a0al (2022) Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV). J\u00a0Eur Acad Dermatol Venereol 36:1689\u20131704","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5241_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00105-021-04773-w","volume":"72","author":"D Didona","year":"2021","unstructured":"Didona\u00a0D, Hertl\u00a0M (2021) Paraneoplastic autoimmune dermatoses. Hautarzt 72:277\u2013287","journal-title":"Hautarzt"},{"key":"5241_CR5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s00105-022-05036-y","volume":"73","author":"D Didona","year":"2022","unstructured":"Didona\u00a0D, Hinterseher\u00a0J, Eming\u00a0R (2022) Bullous autoimmune dermatoses of the mucous membranes. Dermatologie 73:692\u2013700","journal-title":"Dermatologie"},{"key":"5241_CR6","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.jid.2023.02.012","volume":"143","author":"JA Fairley","year":"2023","unstructured":"Fairley\u00a0JA, Crowe\u00a0TP, Fakhimi\u00a0M et\u00a0al (2023) Disease endotypes predict the severity of mucous membrane pemphigoid. J\u00a0Invest Dermatol 143:1479\u20131486.e3","journal-title":"J Invest Dermatol"},{"key":"5241_CR7","first-page":"1530","volume":"20","author":"SC Hofmann","year":"2022","unstructured":"Hofmann\u00a0SC, Gunther\u00a0C, Bockle\u00a0BC et al (2022) S2k-Leitlinie zur Diagnostik und Therapie des Schleimhautpemphigoids. J\u00a0Dtsch Dermatol Ges 20:1530\u20131552","journal-title":"J Dtsch Dermatol Ges"},{"key":"5241_CR8","first-page":"1339","volume":"16","author":"SC Hofmann","year":"2018","unstructured":"Hofmann\u00a0SC, Juratli\u00a0HA, Eming\u00a0R (2018) Bullose Autoimmundermatosen. J\u00a0Dtsch Dermatol Ges 16:1339\u20131360","journal-title":"J Dtsch Dermatol Ges"},{"key":"5241_CR9","first-page":"405","volume":"21","author":"MM Holtsche","year":"2023","unstructured":"Holtsche\u00a0MM, Boch\u00a0K, Schmidt\u00a0E (2023) Autoimmune bullous dermatoses. J\u00a0Dtsch Dermatol Ges 21:405\u2013412","journal-title":"J Dtsch Dermatol Ges"},{"key":"5241_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00105-017-4089-y","volume":"69","author":"MM Holtsche","year":"2018","unstructured":"Holtsche\u00a0MM, Zillikens\u00a0D, Schmidt\u00a0E (2018) Mucous membrane pemphigoid. Hautarzt 69:67\u201383","journal-title":"Hautarzt"},{"issue":"3","key":"5241_CR11","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/ajd.13611","volume":"62","author":"K Simpson","year":"2021","unstructured":"Simpson\u00a0K, Kok\u00a0Y, Vu\u00a0M, Kidd\u00a0D, Yap\u00a0T, Tran\u00a0Y, Kernardamaglia\u00a0JS, Kok\u00a0Y, Vu\u00a0M, Kidd\u00a0D, Yap\u00a0T, Tran\u00a0Y, Kern\u00a0JS (2021) Comparison of the EUROIMMUN Dermatology Profile ELISA to the novel BIOCHIP Mosaic 7 for the diagnosis of immunobullous skin disease. Australas J Dermatol 62(3):314\u2013322","journal-title":"Australas J Dermatol"},{"key":"5241_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/jalm\/jfab147","volume":"7","author":"KM Leiferman","year":"2022","unstructured":"Leiferman\u00a0KM, Snook\u00a0JP, Khalighi\u00a0MA et\u00a0al (2022) Diagnostics for dermatologic diseases with autoantibodies. J\u00a0Appl Lab Med 7:165\u2013196","journal-title":"J Appl Lab Med"},{"key":"5241_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8372146","author":"S Leuci","year":"2018","unstructured":"Leuci\u00a0S, Amato\u00a0M, Calabria\u00a0E et al (2018) Long-term follow-up after intravenous immunoglobulin therapy in patients with severe ocular mucous membrane pemphigoid unresponsive to conventional therapy. J\u00a0Ophthalmol. https:\/\/doi.org\/10.1155\/2018\/8372146","journal-title":"J Ophthalmol"},{"key":"5241_CR14","doi-asserted-by":"publisher","first-page":"1128154","DOI":"10.3389\/fmed.2023.1128154","volume":"10","author":"R Maglie","year":"2023","unstructured":"Maglie\u00a0R, Solimani\u00a0F, Didona\u00a0D et\u00a0al (2023) The cytokine milieu of bullous pemphigoid: current and novel therapeutic targets. Front Med 10:1128154","journal-title":"Front Med"},{"key":"5241_CR15","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00105-023-05209-3","volume":"74","author":"EL Moderegger","year":"2023","unstructured":"Moderegger\u00a0EL, Schmitz\u00a0MJ, Ludwig\u00a0RJ et\u00a0al (2023) Pemphigoid diseases in older adults. Dermatologie 74:687\u2013695","journal-title":"Dermatologie"},{"key":"5241_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.jaad.2011.06.032","volume":"66","author":"DF Murrell","year":"2012","unstructured":"Murrell\u00a0DF, Daniel\u00a0BS, Joly\u00a0P et\u00a0al (2012) Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. J\u00a0Am Acad Dermatol 66:479\u2013485","journal-title":"J Am Acad Dermatol"},{"key":"5241_CR17","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jaad.2014.08.024","volume":"72","author":"DF Murrell","year":"2015","unstructured":"Murrell\u00a0DF, Marinovic\u00a0B, Caux\u00a0F et\u00a0al (2015) Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts. J\u00a0Am Acad Dermatol 72:168\u2013174","journal-title":"J Am Acad Dermatol"},{"key":"5241_CR18","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/jdv.17397","volume":"35","author":"H Rashid","year":"2021","unstructured":"Rashid\u00a0H, Lamberts\u00a0A, Borradori\u00a0L et\u00a0al (2021) European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology\u2014Part I. J\u00a0Eur Acad Dermatol Venereol 35:1750\u20131764","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5241_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/bjd.17146","volume":"180","author":"F Schauer","year":"2019","unstructured":"Schauer\u00a0F, Kern\u00a0JS, Virtic\u00a0O et al (2019) A new clinical variant of acquired reactive perforating dermatosis-like bullous pemphigoid. Br J Dermatol 180:231\u2013232","journal-title":"Br J Dermatol"},{"key":"5241_CR20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1001\/jamadermatol.2021.5294","volume":"158","author":"F Schauer","year":"2022","unstructured":"Schauer\u00a0F, Mai\u00a0S, Hofmann\u00a0SC et\u00a0al (2022) Autoreactivity to BP180 neoepitopes in patients with pemphigoid gestationis. JAMA Dermatol 158:212\u2013214","journal-title":"JAMA Dermatol"},{"key":"5241_CR21","first-page":"713","volume":"13","author":"E Schmidt","year":"2015","unstructured":"Schmidt\u00a0E, Goebeler\u00a0M, Hertl\u00a0M et\u00a0al (2015) S2k guideline for the diagnosis of pemphigus vulgaris\/foliaceus and bullous pemphigoid. J\u00a0Dtsch Dermatol Ges 13:713\u2013727","journal-title":"J Dtsch Dermatol Ges"},{"key":"5241_CR22","first-page":"516","volume":"18","author":"E Schmidt","year":"2020","unstructured":"Schmidt\u00a0E, Sticherling\u00a0M, Sardy\u00a0M et\u00a0al (2020) S2k guidelines for the treatment of pemphigus vulgaris\/foliaceus and bullous pemphigoid: 2019 update. J\u00a0Dtsch Dermatol Ges 18:516\u2013526","journal-title":"J Dtsch Dermatol Ges"},{"key":"5241_CR23","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/jdv.17107","volume":"35","author":"N Van Beek","year":"2021","unstructured":"Van Beek\u00a0N, Weidinger\u00a0A, Schneider\u00a0SW et al (2021) Incidence of pemphigoid diseases in Northern Germany in 2016\u2014first data from the Schleswig-Holstein Registry of Autoimmune Bullous Diseases. J\u00a0Eur Acad Dermatol Venereol 35:1197\u20131202","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"5241_CR24","doi-asserted-by":"publisher","first-page":"adv00224","DOI":"10.2340\/00015555-3457","volume":"100","author":"MJ Verheyden","year":"2020","unstructured":"Verheyden\u00a0MJ, Bilgic\u00a0A, Murrell\u00a0DF (2020) A systematic review of drug-induced pemphigoid. Acta Derm Venereol 100:adv224","journal-title":"Acta Derm Venereol"},{"key":"5241_CR25","doi-asserted-by":"publisher","first-page":"adv11947","DOI":"10.2340\/actadv.v103.11947","volume":"103","author":"K Yilmaz","year":"2023","unstructured":"Yilmaz\u00a0K, Dikmen\u00a0O, Van Beek\u00a0N et\u00a0al (2023) Evaluation of the diagnostic value of oesophageal biopsies for direct Immunofluorescence microscopy in mucous membrane pemphigoid. Acta Derm Venereol 103:adv11947","journal-title":"Acta Derm Venereol"},{"key":"5241_CR26","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s00417-017-3603-3","volume":"255","author":"C You","year":"2017","unstructured":"You\u00a0C, Lamba\u00a0N, Lasave\u00a0AF et\u00a0al (2017) Rituximab in the treatment of ocular cicatricial pemphigoid: a\u00a0retrospective cohort study. Graefes Arch Clin Exp Ophthalmol 255:1221\u20131228","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05241-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-023-05241-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-023-05241-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T08:02:29Z","timestamp":1704700949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-023-05241-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["5241"],"URL":"https:\/\/doi.org\/10.1007\/s00105-023-05241-3","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,16]]},"assertion":[{"value":"19 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2024","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Erratum","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Zu diesem Beitrag wurde ein Erratum ver\u00f6ffentlicht:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00105-023-05283-7","URL":"https:\/\/doi.org\/10.1007\/s00105-023-05283-7","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.S.\u00a0Kern und S.C.\u00a0Hofmann geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag enth\u00e4lt keine von der Industrie unterst\u00fctzten Inhalte.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patient\/-innen zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern\/Vertreterinnen eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}